Iris Roth

Business address
C/O Zentalis Pharmaceuticals, Inc., 530 Seventh Avenue, Suite 2201, New York, NY, 10018
Top holdings (ownership)
ZNTL
Get insider transactions for this reporting owner
Iris Roth has filed 2 SEC EDGAR filings since 13 Feb 2023

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 02 Mar 2023 01 Mar 2023 001-39263
3 Open Document Open Filing FORM 3 13 Feb 2023 13 Feb 2023 001-39263